The World Health Organization (WHO) has published updated guidance on providing care for people with lymphoedema and other consequences of lymphatic filariasis (LF), a debilitating neglected tropical disease that is endemic in 72 countries globally. LF infection occurs when filarial parasites are transmitted to humans through mosquitoes, is usually acquired in childhood and can cause hidden damage to the lymphatic system.
The updated WHO guidance addresses:
- how to collect information on the numbers of people with lymphoedema and hydrocele
- the policies needed to successfully provide sustainable services for these patients
- how to build capacity for health system staff in providing high-quality care
- how to monitor care provided
- how to evaluate the quality of care provided
Further information and advice on LF is available for health professionals on the TRAVAX website.
Source: ECDC, 5 March 2021